Skip to content
Screener

STERIS STE Non-Controlling Interests

Non-Controlling Interests at other companies

Baxter International logo
Baxter InternationalBAX
-$27M0.0%
Ecolab logo
EcolabECL
$28.9M
3M logo
3MMMM
$53M
Fortive logo
FortiveFTV
$8.8M+23.9%
Intuitive Surgical logo
Intuitive SurgicalISRG
$129.3M+20.4%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$6.35M+0.7%

Other financials

Income statement

See full
Revenue$1.5B+7.3%
Gross profit$684.2M+8.9%
Operating income$285.8M+16.2%
Net income$200.1M+12.8%
EPS (diluted)$2.04+14.0%

Balance sheet

See full
Cash & equivalents$482.3M+72.4%
Total debt$1.9B-2.3%
Total equity$7.2B+3.8%
Total assets$10.7B+3.2%

Cash flow

See full
Operating cash flow$367.1M-12.6%
CapEx$87.5M-6.5%
Free cash flow$279.6M-14.3%

Valuation

See full
Market cap$22.68B+4.2%
Enterprise value$24.09B+2.9%
P/E28.2×-5.5×
P/S3.8×-0.1×

Profitability

See full
Gross margin44.4%+0.3pp
Operating margin18.9%+2.3pp
Net margin13.3%+1.7pp
FCF margin15.3%-1.0pp

Returns & leverage

See full
Return on equity11.4%+1.6pp
Debt / equity0.3×0.0×
Current ratio1.9×-0.3×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: STERIS’s 10-K, filed May 29, 2026.

Filed
May 29, 2026, 4:04 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-039136
March 31,20262025
Commitments and contingencies (see Note 12)
Ordinary shares, with $0.001 par value; 500.0 shares authorized; 97.8 and 98.3 ordinary shares issued and outstanding, respectively4,280.94,420.4
Retained earnings3,015.92,475.3
Accumulated other comprehensive loss(113.1)(292.3)
Total shareholders’ equity7,183.66,603.4
Noncontrolling interests13.612.4
Total equity7,197.26,615.8
Total liabilities and equity$10,737.2$10,146.8

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is STERIS's non-controlling interests?
STERIS (STE) reported non-controlling interests of $13.6M in Q1 2026.
How has STERIS's non-controlling interests changed year-over-year?
STERIS's non-controlling interests increased by 9.7% year-over-year, from $12.4M to $13.6M.
What is the long-term trend for STERIS's non-controlling interests?
Over 5 years (2021 to 2026), STERIS's non-controlling interests has grown at a 5.4% compound annual growth rate (CAGR), from $10.48M to $13.6M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.

Ask your AI about STERIS's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude